These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29101816)

  • 1. Improved liquid chromatographic method for quality control of spiramycin using superficially porous particles.
    Lin Q; Kahsay G; de Waal T; Zhu P; Tam M; Teughels R; Wang W; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2018 Feb; 149():57-65. PubMed ID: 29101816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mass spectrometer-compatible liquid chromatographic method for the analysis of tylosin and its impurities using a superficially porous particle column.
    Lin Q; de Waal T; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2019 Feb; 165():147-154. PubMed ID: 30544049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design: a systematic and rapid liquid chromatography and mass spectrometry method for eprosartan mesylate and its related impurities using a superficially porous particle column.
    Kalariya PD; Kumar Talluri MV; Gaitonde VD; Devrukhakar PS; Srinivas R
    J Sep Sci; 2014 Aug; 37(16):2160-71. PubMed ID: 24913516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impurity profiling of acetylspiramycin by liquid chromatography-ion trap mass spectrometry.
    Wang MJ; Pendela M; Hu CQ; Jin SH; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2010 Oct; 1217(42):6531-44. PubMed ID: 20843520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
    Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
    J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized analysis for related substances in spiramycin based on high performance liquid chromatography with hybrid particle column and characterization of its impurities by single heartcut two-dimensional liquid chromatography coupled with quadrupole time-of-flight mass spectrometer.
    Yao Y; Wang Q; Lu Y; Zhang J; Yao W; Yuan Y
    J Pharm Biomed Anal; 2025 Jan; 252():116486. PubMed ID: 39326378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the stability indicating RP-UHPLC method for the determination of the chemical purity and assay of bimatoprost.
    Zezula M; Ruszczak M; Maruszak W; Zagrodzka J; Chodynski M; Dams I
    J Pharm Biomed Anal; 2019 Sep; 174():348-359. PubMed ID: 31202877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated UHPLC method for the determination of caffeoylquinic and di-caffeoylquinic acids in green coffee extracts using an RP-Amide fused-core column.
    Fibigr J; Majorová M; Kočová Vlčková H; Solich P; Šatínský D
    J Pharm Biomed Anal; 2018 Mar; 151():291-300. PubMed ID: 29413977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a reversed phase liquid chromatographic method for analysis of griseofulvin and impurities.
    Kahsay G; Adegoke AO; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2013 Jun; 80():9-17. PubMed ID: 23518305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a reversed-phase liquid chromatographic method for analysis of demeclocycline and related impurities.
    Kahsay G; Maxa J; Van Schepdael A; Hoogmartens J; Adams E
    J Sep Sci; 2012 Jun; 35(10-11):1310-8. PubMed ID: 22733511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
    Venugopal N; Bhaskar Reddy AV; Gangadhar Reddy K; Madhavi V; Madhavi G
    J Pharm Biomed Anal; 2012 Nov; 70():592-7. PubMed ID: 22749172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical comparison of 2.7 microm fused-core silica particles and porous sub-2 microm particles for fast separations in pharmaceutical process development.
    Abrahim A; Al-Sayah M; Skrdla P; Bereznitski Y; Chen Y; Wu N
    J Pharm Biomed Anal; 2010 Jan; 51(1):131-7. PubMed ID: 19758782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of impurities level of perindopril tert-butylamine in tablets.
    Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
    J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.